Research Article

Analysis of the Cytokine Expression in the Aqueous Humor of Individuals with BRVO-Associated Macular Edema

Table 1

Clinical and demographic data.

IndexNumerical value

Age67.46 ± 8.35 years
Sex (F/M)27/31
Duration of the disease15 (9, 15) days
Eye type (R/L)28/30
Obstruction sites (ST/IT)38/20
IOP13.53 ± 2.19 mm·Hg
BCVA (logMAR)0.5 (0.9, 0.4)
CMT494 (369, 587) μ·m
Hypertension (Thirty-one/53.45%)
 SBP157.36 ± 24.72 mm·Hg
 DBP95.53 ± 18.45 mm·Hg
Diabetes (twenty-one/34.48%)
 Baseline HbA1c7.9 (6.5, 9.6)%
 FBS10.82 ± 1.61 mmol/L
Hyperlipidemia (eight/13.79%)
 TC4.28 ± 0.79 mmol/L
 TG2.12 ± 0.39 mmol/L
 HDL-C1.07 ± 0.17 mmol/L
 LDL-C2.76 ± 0.15 mmol/L

ST, superior temporal; IT, inferior temporal; IOP, intraocular pressure; BCVA, best-corrected visual acuity; logMAR, logarithm of the minimum angle of resolution; CMT, central macular thickness; SBP, Systolic blood pressure; DBP, diastolic blood pressure; HbA1c, glycated haemoglobin; FBS, fasting blood sugar; TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol.